These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23665775)

  • 1. A case of malignant insulinoma: successful control of glycemic fluctuation by replacing octreotide injections with octreotide LAR injections.
    Okamoto M; Kishimoto M; Takahashi Y; Osame K; Noto H; Yamamoto-Honda R; Kajio H; Tokuhara M; Edamoto Y; Endo H; Igari T; Kubota K; Noda M
    Endocr J; 2013; 60(8):951-7. PubMed ID: 23665775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical treatment of benign insulinoma using octreotide LAR: a case report.
    Usukura M; Yoneda T; Oda N; Yamamoto Y; Takata H; Hasatani K; Takeda Y
    Endocr J; 2007 Feb; 54(1):95-101. PubMed ID: 17124362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe hypoglycaemia after long-acting octreotide in a patient with an unrecognized malignant insulinoma.
    Healy ML; Dawson SJ; Murray RM; Zalcberg J; Jefford M
    Intern Med J; 2007 Jun; 37(6):406-9. PubMed ID: 17535385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggravation of hypoglycemia in insulinoma patients by the long-acting somatostatin analogue octreotide (Sandostatin).
    Stehouwer CD; Lems WF; Fischer HR; Hackeng WH; Naafs MA
    Acta Endocrinol (Copenh); 1989 Jul; 121(1):34-40. PubMed ID: 2545062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pasireotide for malignant insulinoma.
    Tirosh A; Stemmer SM; Solomonov E; Elnekave E; Saeger W; Ravkin Y; Nir K; Talmor Y; Shimon I
    Hormones (Athens); 2016 Apr; 15(2):271-276. PubMed ID: 26732164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful long-term treatment with once-daily injection of low-dose octreotide in an aged patient with insulinoma.
    Katabami T; Kato H; Shirai N; Naito S; Saito N
    Endocr J; 2005 Oct; 52(5):629-34. PubMed ID: 16284444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete clinical remission and disappearance of liver metastases after treatment with somatostatin analogue in a 40-year-old woman with a malignant insulinoma positive for somatostatin receptors type 2.
    Romeo S; Milione M; Gatti A; Fallarino M; Corleto V; Morano S; Baroni MG
    Horm Res; 2006; 65(3):120-5. PubMed ID: 16479142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful control of intractable hypoglycemia using radiopharmaceutical therapy with strontium-89 in a case with malignant insulinoma and bone metastases.
    Naganuma A; Mayahara H; Morizane C; Ito Y; Hagihara A; Kondo S; Ueno H; Itami J; Okusaka T
    Jpn J Clin Oncol; 2012 Jul; 42(7):640-5. PubMed ID: 22525212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of insulinoma by a single daily dose of octreotide in two elderly female patients.
    Kishikawa H; Okada Y; Hirose A; Tanikawa T; Kanda K; Tanaka Y
    Endocr J; 2006 Feb; 53(1):79-85. PubMed ID: 16543676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of Extrapancreatic Glucagon by Octreotide May Reduce the Fasting and Postprandial Glucose Levels in a Diabetic Patient after Total Pancreatectomy.
    Okuma H; Bouchi R; Masuda S; Takeuchi T; Murakami M; Minami I; Izumiyama H; Hashimoto K; Yoshimoto T; Ogawa Y
    Intern Med; 2017 Nov; 56(22):3061-3066. PubMed ID: 28943578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic treatment of a benign insulinoma using the long-acting somatostatin analogue SMS 201-995.
    Glaser B; Rösler A; Halperin Y
    Isr J Med Sci; 1990 Jan; 26(1):16-9. PubMed ID: 2155884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies.
    Vezzosi D; Bennet A; Rochaix P; Courbon F; Selves J; Pradere B; Buscail L; Susini C; Caron P
    Eur J Endocrinol; 2005 May; 152(5):757-67. PubMed ID: 15879362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No effect of the long-acting somatostatin analogue octreotide in patients with insulinoma.
    Timmer R; Koningsberger JC; Erkelens DW; Thijssen JH; Lips CJ; Koppeschaar HP
    Neth J Med; 1991 Jun; 38(5-6):199-203. PubMed ID: 1922592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insulinoma and octreotide].
    Stehouwer C
    Ned Tijdschr Geneeskd; 1992 Jun; 136(25):1221. PubMed ID: 1614574
    [No Abstract]   [Full Text] [Related]  

  • 15. Everolimus dramatically improves glycemic control in unresectable metastatic insulinoma: a case report.
    Asayama M; Yamada-Murano T; Hara H; Ooki A; Kurosumi M; Yamaguchi K
    Jpn J Clin Oncol; 2014 Feb; 44(2):186-90. PubMed ID: 24367043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-responsive and octreotide-sensitive insulinoma.
    Izumiyama H; Gotyo N; Fukai N; Ozawa N; Doi M; Yoshimoto T; Arii S; Hirata Y
    Intern Med; 2006; 45(8):519-24. PubMed ID: 16702744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the long-acting somatostatin analogue octreotide in the management of insulinoma in three dogs.
    Simpson KW; Stepien RL; Elwood CM; Boswood A; Vaillant CR
    J Small Anim Pract; 1995 Apr; 36(4):161-5. PubMed ID: 7603057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with somatostatin analogs and chemoembolization of liver metastases for severe hypoglycemia in malignant insulinomas.
    Maiza JC; Vezzosi D; Grunenwald S; Otal P; Guimbaud R; Bennet A; Caron P
    J Endocrinol Invest; 2011 Oct; 34(9):e253-8. PubMed ID: 21623151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of glucagon administration in the diagnosis and treatment of patients with tumor hypoglycemia.
    Hoff AO; Vassilopoulou-Sellin R
    Cancer; 1998 Apr; 82(8):1585-92. PubMed ID: 9554538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of hypoglycemia with octreotide therapy in metastatic insulinoma with positive octreotide scan.
    Wade AN; Cheng G; Teitelbaum U; Patel AA; Alavi A; Rickels MR
    Pancreas; 2011 Jan; 40(1):173-5. PubMed ID: 21160385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.